atomoxetine hydrochloride has been researched along with Chronic Motor and Vocal Tic Disorder in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, YH; Fang, F; Jiang, L; Jiang, YW; Liu, ZS; Lu, Q; Luo, R; Peng, J; Qin, J; Sun, D; Wang, JQ; Zheng, Y; Zhou, SZ | 1 |
| Liu, MX; Xu, T; Zhou, Y | 1 |
| Bloch, MH; Landeros-Weisenberger, A; Leckman, JF; Panza, KE | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Bender, S; Buse, J; Ehrlich, S; Münchau, A; Roessner, V; Schoenefeld, K | 1 |
| Acosta, MT; Castellanos, FX | 1 |
| Robertson, MM | 1 |
| Badreldin, N; Gilbert, DL; Lipps, TD; Merhar, S; Ridel, KR; Sallee, FR; Wang, Z; Wassermann, EM; White, C; Zhang, J | 1 |
| Benarroch, F; Gross-Tsur, V; Jaworowski, S | 1 |
| Niederhofer, H | 1 |
| Brandyberry, J; Gilbert, DL; Lipps, TD; Natarajan, N; Sallee, FR; Wang, Z; Wassermann, EM; Zhang, J | 1 |
| Allen, AJ; Budman, CL; Coffey, BJ; Dunn, DW; Feldman, PD; Geller, DA; Gilbert, DL; Kelsey, DK; Kurlan, RM; Leonard, HL; Lewis, DW; Linder, SL; McCracken, JT; Milton, DR; Mintz, M; Ricardi, RK; Sallee, FR; Spencer, TJ; Winner, PK | 1 |
3 review(s) available for atomoxetine hydrochloride and Chronic Motor and Vocal Tic Disorder
| Article | Year |
|---|---|
Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
Topics: Adrenergic alpha-Agonists; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Contraindications; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Methylphenidate; Propylamines; Psychotropic Drugs; Randomized Controlled Trials as Topic; Tic Disorders; Tourette Syndrome | 2009 |
Pharmacological treatment of tic disorders and Tourette Syndrome.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Dopamine Antagonists; Humans; Pimozide; Propylamines; Risperidone; Tiapride Hydrochloride; Tic Disorders; Tourette Syndrome | 2013 |
Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Methylphenidate; Propylamines; Tics; Tourette Syndrome | 2006 |
2 trial(s) available for atomoxetine hydrochloride and Chronic Motor and Vocal Tic Disorder
| Article | Year |
|---|---|
Dopamine transporter genotype influences the physiological response to medication in ADHD.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Female; Genotype; Humans; Male; Methylphenidate; Motor Cortex; Neural Inhibition; Pharmacogenetics; Phenotype; Propylamines; Tourette Syndrome; Treatment Outcome | 2006 |
Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Double-Blind Method; Female; Humans; Male; Propylamines; Severity of Illness Index; Tourette Syndrome | 2008 |
7 other study(ies) available for atomoxetine hydrochloride and Chronic Motor and Vocal Tic Disorder
| Article | Year |
|---|---|
[Investigation on the status of monotherapy for newly diagnosed tic disorders and its comorbidity in children].
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Female; Humans; Male; Tic Disorders; Tourette Syndrome | 2020 |
[Treatment of Tourette syndrome by tomoxetine hydrochloride in older children].
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Child; Female; Humans; Male; Propylamines; Tourette Syndrome | 2014 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
[Tourette syndrome: an analysis of its comorbidity and specific treatment].
Topics: Adrenergic alpha-Agonists; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Comorbidity; Guanfacine; Humans; Obsessive-Compulsive Disorder; Propylamines; Tourette Syndrome | 2004 |
Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Clonidine; Comorbidity; Drug Therapy, Combination; Humans; Male; Methylphenidate; Propylamines; Tics; Tourette Syndrome | 2006 |
Is atomoxetine also effective in patients suffering from Tourette syndrome?
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Electroencephalography; Humans; Male; Neuropsychological Tests; Propylamines; Tourette Syndrome; Treatment Outcome | 2006 |
Atomoxetine treatment of ADHD in Tourette syndrome: reduction in motor cortex inhibition correlates with clinical improvement.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cohort Studies; Female; Humans; Male; Motor Cortex; Neural Inhibition; Propylamines; Severity of Illness Index; Single-Blind Method; Time Factors; Tourette Syndrome; Transcranial Magnetic Stimulation; Treatment Outcome | 2007 |